Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients

Journal of the American College of Cardiology

Volumn 61, Issue 24, 2013, Pages 2461-2467

  De Nicola, Luca ^a   Gabbai, Francis B ^b   Agarwal, Rajiv ^c   Chiodini, Paolo ^a   Borrelli, Silvio ^a   Bellizzi, Vincenzo ^d   Nappi, Felice ^e   Conte, Giuseppe ^a   Minutolo, Roberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Hospital of Salerno   (Italy)

^e Nola Hospital   (Italy)

Author keywords

ambulatory blood pressure monitoring; chronic kidney disease; resistant hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; RESISTANT HYPERTENSION; SURVIVAL;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84878939488     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.12.061     Document Type: Article

References (37)

1. A.V. Chobanian, G.L. Bakris, and H.R. Black Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
2. Kidney Diseases Outcomes Quality Initiative (K/DOQI) K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 43 Suppl 1 2004 S1 S290
3. G. Mancia, G. De Backer, A. Dominiczak Management of arterial hypertension of the European Society of Hypertension; European Society of Cardiology 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187
4. R.D. Toto Debate: PRO position. People with chronic kidney disease should have a blood pressure lower than 130/80 mm Hg Am J Nephrol 32 2010 370 373 discussion 379-80
5. R. Agarwal Debate: CON position. People with chronic kidney disease should have a blood pressure lower than 130/80 mm Hg Am J Nephrol 32 2010 374 376
6. J.B. Lewis Blood pressure control in chronic kidney disease. Is less really more? J Am Soc Nephrol 21 2010 1086 1092
7. L.J. Appel, J.T. Wright Jr., and T. Greene Intensive blood-pressure control in hypertensive chronic kidney disease N Engl J Med 363 2010 918 929
8. A. Upadhyay, A. Earley, S.M. Haynes, and K. Uhlig Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier Ann Intern Med 154 2011 541 548
9. C.A. Peralta, K.C. Norris, and S. Li Blood pressure components and end-stage renal disease in persons with chronic kidney disease. The Kidney Early Evaluation Program (KEEP) Arch Intern Med 172 2012 41 47
10. L. De Nicola, P. Chiodini, and C. Zoccali Prognosis of CKD patients receiving outpatient nephrology care in Italy Clin J Am Soc Nephrol 6 2011 2421 2428
11. R. Minutolo, S. Borrelli, and R. Scigliano Prevalence and clinical correlates of white coat hypertension in chronic kidney disease Nephrol Dial Transplant 22 2007 2217 2223
12. R. Minutolo, S. Borrelli, and P. Chiodini Effects of age on hypertensive status in patients with chronic kidney disease J Hypertens 25 2007 2325 2333
13. R. Agarwal, and M.J. Andersen Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease Kidney Int 69 2006 1175 1180
14. R. Minutolo, R. Agarwal, and S. Borrelli Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease Arch Intern Med 171 2011 1090 1098
15. D.A. Calhoun, D. Jones, and S. Textor Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 2008 510 526
16. P.A. Sarafidis, and G.L. Bakris Resistant hypertension: an overview of evaluation and treatment J Am Coll Cardiol 52 2008 1749 1757
17. S.L. Daugherty, J.D. Powers, and D.J. Magid Incidence and prognosis of resistant hypertension in hypertensive patients Circulation 125 2012 1635 1642
18. G. Salles, C. Cardoso, and E. Muxfeldt Prognostic influence of office and ambulatory blood pressures in resistant hypertension Arch Intern Med 168 2012 2340 2346
19. A. De la Sierra, J. Segura, and J.R. Banegas Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring Hypertension 57 2011 898 902
20. L. De Nicola, S. Borrelli, and F.B. Gabbai Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease Kidney Blood Press Res 34 2011 58 67
21. E. O'Brien, R. Asmar, and L. Beilin European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement J Hypertension 21 2003 821 848
22. M. Kikuya, T.W. Hansen, and L. Thijs Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk Circulation 115 2007 2145 2152
23. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
24. R.V. Luepker, F.S. Apple, and R.H. Christenson Case definitions for acute coronary heart disease in epidemiology and clinical research studies. A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation 108 2003 2543 2549
25. B.F. Palmer Renal dysfunction complicating the treatment of hypertension New Engl J Med 347 2002 1256 1261
26. G. Salles, C. Cardoso, R. Fiszman, and E. Muxfeldt Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension Atherosclerosis 216 2011 199 204
27. G.F. Salles, C.R. Cardoso, V.S. Pereira, R. Fiszman, and E.S. Muxfeldt Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study J Hypertens 29 2011 2014 2023
28. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
29. M.P. Kao, D.S. Ang, and S.J. Gandy Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease J Am Soc Nephrol 22 2011 1382 1389
30. A.I. Christen, R.L. Armentano, and A. Miranda Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings Curr Diabetes Rev 6 2010 367 377
31. M.R. Weir, R.R. Townsend, and J.C. Fink Hemodynamic correlates of proteinuria in chronic kidney disease Clin J Am Soc Nephrol 6 2011 2403 2410
32. P.W. Sanders Vascular consequences of dietary salt intake Am J Physiol Renal Physiol 297 2009 F237 F243
33. E. Pimenta, K.K. Gaddam, and S. Oparil Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial Hypertension 54 2009 475 481
34. L. De Nicola, R. Minutolo, and V. Bellizzi Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am J Kidney Dis 43 2004 782 795
35. B.D. Rose Diuretics Kidney Int 39 1991 336 352
36. R.C. Hermida, C. Calvo, D.E. Ayala, J.R. Fernández, L.M. Ruilope, and J.E. López Evaluation of the extent and duration of the "ABPM effect" in hypertensive patients J Am Coll Cardiol 40 2002 710 717
37. R.H. Fagard Resistant hypertension Heart 98 2012 254 261